AUY922
- Generic Name
- AUY922
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H33N3O5
- CAS Number
- 747412-64-2
- Unique Ingredient Identifier
- G1G66XE93W
- Background
AUY922 has been used in trials studying the treatment of Lymphoma, Breast Cancer, Metastatic Disease, Advanced Solid Tumors, and Hematologic Neoplasms, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy
Phase 2
Terminated
- Conditions
- Adenocarcinoma of the PancreasMetastatic Disease
- Interventions
- First Posted Date
- 2011-12-02
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 15
- Registration Number
- NCT01484860
- Locations
- 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath